BlackRock Institutional Trust’s Regenxbio RGNX Stock Holding History

BlackRock Institutional Trust’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10.2M	Buy	552,022 +243,617	+79%	+$4.66M	﹤0.01%	2393
2016 Q3	$4.32M	Buy	308,405 +138,085	+81%	+$1.52M	﹤0.01%	2751
2016 Q2	$1.36M	Buy	170,320 +111,499	+190%	+$1.24M	﹤0.01%	3194
2016 Q1	$635K	Buy	58,821 +27,960	+91%	+$358K	﹤0.01%	3400
2015 Q4	$512K	Buy	30,861 +30,055	+3,729%	+$597K	﹤0.01%	3505
2015 Q3	$18K	Buy	+806	New	+$20.6K	﹤0.01%	3897

Other funds holding RGNX

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BlackRock Institutional Trust's RGNX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Regenxbio (RGNX) stake by 79% in Q4 2016, buying an estimated $4.66M and bringing the position to 552,022 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2393.

BlackRock Institutional Trust first reported a position in RGNX in Q3 2015 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

BlackRock Institutional Trust held 552,022 shares of Regenxbio worth $10.2M as of Q4 2016.
BlackRock Institutional Trust bought 243,617 Regenxbio shares in Q4 2016, an estimated $4.66M.
Regenxbio made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2393 holding.
BlackRock Institutional Trust first reported a position in Regenxbio in Q3 2015 and has held it in 6 quarters since.
78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.